Joel Barrish
2016
In 2016, Joel Barrish earned a total compensation of $2.7M as Executive Vice President and Chief Scientific Officer at Achillion Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $339,023 |
|---|---|
| Option Awards | $1,938,425 |
| Salary | $423,077 |
| Other | $45,638 |
| Total | $2,746,163 |
Barrish received $1.9M in option awards, accounting for 71% of the total pay in 2016.
Barrish also received $339K in non-equity incentive plan, $423.1K in salary and $45.6K in other compensation.
Rankings
In 2016, Joel Barrish's compensation ranked 3,543rd out of 14,075 executives tracked by ExecPay. In other words, Barrish earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,543 out of 14,075 | 75th |
Division Manufacturing | 1,233 out of 5,486 | 78th |
Major group Chemicals And Allied Products | 371 out of 1,900 | 81st |
Industry group Drugs | 269 out of 1,543 | 83rd |
Industry Pharmaceutical Preparations | 213 out of 1,173 | 82nd |
Source: SEC filing on April 17, 2017.
Barrish's colleagues
We found four more compensation records of executives who worked with Joel Barrish at Achillion Pharmaceuticals in 2016.
2016
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2016
David Apelian
Achillion Pharmaceuticals
Chief Medical Officer
2016
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2016
Mary Fenton
Achillion Pharmaceuticals